NEW YORK (GenomeWeb News) — Case Western Reserve University has received a grant worth up to $3 million from the National Institute of Drug Abuse to conduct proteomic studies of Hepatitis C and HIV infections, Case's School of Medicine said today.

The three-year NIDA grant will fund development of proteomic and epigenetic markers for chronic immune activation during HIV disease and studies of the effects of current and prior drug use and HCV infection on disease progression and therapy.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.